Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET Acetate for Docetaxel Response Assessment in Hormone-Refractory Prostate Cancer

NCT01144897 is registered in ClinicalTrials.gov with Daniel Vaena as lead sponsor.

NCT NCT01144897
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01144897 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET Acetate for Docetaxel Response Assessment in Hormone-Refractory Prostate Cancer
Lead sponsor
Daniel Vaena
Phase
Phase 1
Overall status
Completed
Start date
May 31, 2010
Completion date
September 30, 2018
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castrate resistant prostate cancer, prostate cancer